B. Ljungberg, S. C. Campbell, and H. Choi, The Epidemiology of Renal Cell Carcinoma, European Urology, vol.60, issue.4, pp.615-621, 2011.
DOI : 10.1016/j.eururo.2011.06.049

A. Rubagotti, G. Martorana, and F. Boccardo, Epidemiology of Kidney Cancer, European Urology Supplements, vol.5, issue.8, pp.558-565, 2006.
DOI : 10.1016/j.eursup.2006.03.008

S. Naito, Y. Tomita, and S. Rha, Kidney Cancer Working Group Report, Japanese Journal of Clinical Oncology, vol.40, issue.Supplement 1, pp.51-56, 2010.
DOI : 10.1093/jjco/hyq127

N. Nese, G. Paner, and K. Mallin, Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47???909 cases using the National Cancer Data Base, Annals of Diagnostic Pathology, vol.13, issue.1, pp.1-8, 2009.
DOI : 10.1016/j.anndiagpath.2008.10.002

W. Chow, L. Dong, and S. Devesa, Epidemiology and risk factors for kidney cancer, Nature Reviews Urology, vol.4, issue.5, pp.245-257, 2010.
DOI : 10.1038/nrurol.2010.46

P. Cairns, Renal cell carcinoma, Cancer Biomarkers, vol.9, issue.1-6, pp.461-473, 2010.
DOI : 10.3233/CBM-2011-0176

L. Macleod, J. Hotaling, and J. Wright, Risk Factors for Renal Cell Carcinoma in the VITAL Study, The Journal of Urology, vol.190, issue.5, pp.1657-1661, 2013.
DOI : 10.1016/j.juro.2013.04.130

M. Purdue, L. Moore, and M. Merino, An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies, International Journal of Cancer, vol.170, issue.11, pp.2640-2647, 2013.
DOI : 10.1002/ijc.27934

URL : https://hal.archives-ouvertes.fr/hal-01261743

T. Pischon, P. Lahmann, and H. Boeing, Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC), International Journal of Cancer, vol.33, issue.6869, pp.728-738, 2006.
DOI : 10.1002/ijc.21398

A. Renehan, M. Tyson, and M. Egger, Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies, The Lancet, vol.371, issue.9612, pp.569-578, 2008.
DOI : 10.1016/S0140-6736(08)60269-X

S. Weikert, H. Boeing, and T. Pischon, Blood Pressure and Risk of Renal Cell Carcinoma in the European Prospective Investigation into Cancer and Nutrition, American Journal of Epidemiology, vol.167, issue.4, pp.438-446, 2008.
DOI : 10.1093/aje/kwm321

J. Hunt, O. Van-der-hel, and G. Mcmillan, Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies, International Journal of Cancer, vol.128, issue.1, pp.101-108, 2005.
DOI : 10.1002/ijc.20618

S. Weikert, H. Boeing, and T. Pischon, Fruits and vegetables and renal cell carcinoma: Findings from the European prospective investigation into cancer and nutrition (EPIC), International Journal of Cancer, vol.78, issue.12, pp.3133-3139, 2006.
DOI : 10.1002/ijc.21765

E. Singer and G. Gupta, Targeted therapeutic strategies for the management of renal cell carcinoma, Current Opinion in Oncology, vol.24, issue.3, pp.284-290
DOI : 10.1097/CCO.0b013e328351c646

D. Su, L. Stamatakis, E. Singer, and R. Srinivasan, Renal cell carcinoma, Current Opinion in Oncology, vol.26, issue.3, pp.321-327, 2014.
DOI : 10.1097/CCO.0000000000000069

K. Hl, . Belldegrun-as, and . Freitas-dg, Paraneoplastic Signs and Symptoms of Renal Cell Carcinoma: Implications for Prognosis, J Urol, vol.170, pp.1742-1746, 2003.

A. Rodríguez, J. Patard, and B. Lobel, Renal cell carcinoma in young adults: incidence, disease outcome and review of the literature, Arch Esp Urol, vol.55, pp.969-975, 2002.

F. Algaba, H. Akaza, and A. López-b-eltrán, Current Pathology Keys of Renal Cell Carcinoma, European Urology, vol.60, issue.4, pp.634-643, 2011.
DOI : 10.1016/j.eururo.2011.06.047

A. Lopez-beltran, M. Scarpelli, R. Montironi, and Z. Kirkali, 2004 WHO Classification of the Renal Tumors of the Adults, European Urology, vol.49, issue.5, pp.798-805, 2004.
DOI : 10.1016/j.eururo.2005.11.035

R. Motzer, Prognostic factors and clinical trials of new agents in patients with metastatic renal cell carcinoma, Critical Reviews in Oncology/Hematology, vol.46, pp.33-39, 2003.
DOI : 10.1016/S1040-8428(03)00062-3

R. Motzer, J. Bacik, and M. Mazumdar, Prognostic Factors for Survival of Patients with Stage IV Renal Cell Carcinoma: Memorial Sloan-Kettering Cancer Center Experience, Clinical Cancer Research, vol.10, issue.18, pp.6302-6303, 2004.
DOI : 10.1158/1078-0432.CCR-040031

M. Sun, S. Shariat, and C. Cheng, Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review, European Urology, vol.60, issue.4, pp.644-661, 2011.
DOI : 10.1016/j.eururo.2011.06.041

B. Escudier, T. Eisen, and C. Porta, Renal cell carcinoma: ESMO Clinical P ractice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.23, pp.65-71, 2012.

D. Heng, W. Xie, and M. Regan, External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study, The Lancet Oncology, vol.14, issue.2, pp.141-148, 2013.
DOI : 10.1016/S1470-2045(12)70559-4

R. Kanzaki, M. Higashiyama, and A. Fujiwara, Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience, European Journal of Cardio-Thoracic Surgery, vol.39, issue.2, pp.167-172, 2011.
DOI : 10.1016/j.ejcts.2010.05.021

G. Israel and M. Bosniak, An update of the Bosniak renal cyst classification system, Urology, vol.66, issue.3, pp.484-488, 2005.
DOI : 10.1016/j.urology.2005.04.003

R. Leder, Radiological approach to renal cysts and the Bosniak classification system, Current Opinion in Urology, vol.9, issue.2, pp.129-133, 1999.
DOI : 10.1097/00042307-199903000-00007

L. Rochelle, J. Wood, C. Bex, and A. , Refining the Use of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma, Seminars in Oncology, vol.40, issue.4, pp.429-435, 2013.
DOI : 10.1053/j.seminoncol.2013.05.007

D. Kunkle, A. Kutikov, and R. Uzzo, Management of Small Renal Masses, Seminars in Ultrasound, CT and MRI, vol.30, issue.4, pp.352-358, 2009.
DOI : 10.1053/j.sult.2009.03.002

P. Wagstaff, P. Zondervan, R. Jjmch-de-la, and M. Laguna, The Role of Imaging in the Active Surveillance of Small Renal Masses, Current Urology Reports, vol.115, issue.3, pp.1-8, 2014.
DOI : 10.1007/s11934-013-0386-x

A. Alasker, S. Williams, and R. Ghavamian, Small Renal Mass: To Treat or Not To Treat, Current Urology Reports, vol.180, issue.1, pp.13-18, 2013.
DOI : 10.1007/s11934-012-0296-3

R. Motzer and N. Bander, Renal-Cell Carcinoma, New England Journal of Medicine, vol.335, issue.12, pp.865-875, 1996.
DOI : 10.1056/NEJM199609193351207

R. Motzer, T. Hutson, and P. Tomczak, Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma, New England Journal of Medicine, vol.356, issue.2, pp.115-124, 2007.
DOI : 10.1056/NEJMoa065044

G. Banumathy and P. Cairns, Signaling pathways in renal cell carcinoma, Cancer Biology & Therapy, vol.7, issue.7, pp.658-664, 2010.
DOI : 10.1200/JCO.2008.20.0766

E. Jonasch, P. Futreal, and I. Davis, State of the Science: An Update on Renal Cell Carcinoma, Molecular Cancer Research, vol.10, issue.7, pp.859-880, 2012.
DOI : 10.1158/1541-7786.MCR-12-0117

A. Albini, D. Noonan, and N. Ferrari, Molecular Pathways for Cancer Angioprevention, Clinical Cancer Research, vol.13, issue.15, pp.4320-4325, 2007.
DOI : 10.1158/1078-0432.CCR-07-0069

I. Cho and C. J. , Current Status of Targeted Therapy for Advanced Renal Cell Carcinoma, Korean Journal of Urology, vol.53, issue.4, 2012.
DOI : 10.4111/kju.2012.53.4.217

M. Gross-goupil and B. Escudier, Targeted therapies: sequential and combined treatments, pp.65-71, 2010.

B. Escudier, A. Pluzanska, and P. Koralewski, Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial, The Lancet, vol.370, issue.9605, pp.2103-2111, 2007.
DOI : 10.1016/S0140-6736(07)61904-7

A. Méjean and T. Lebret, Prise en charge du cancer r??nal m??tastatique, Progr??s en Urologie, vol.18, issue.7, pp.298-308, 2008.
DOI : 10.1016/S1166-7087(08)74558-5

B. Escudier and V. Kataja, Renal cell carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up, Annals of Oncology, vol.20, issue.Supplement 4, pp.81-82, 2009.
DOI : 10.1093/annonc/mdp137

J. Faris and M. Michaelson, Targeted therapies: Sunitinib versus interferon-?? in metastatic RCC, Nature Reviews Clinical Oncology, vol.10, issue.1, pp.7-8, 2010.
DOI : 10.1038/nrclinonc.2009.173

B. Escudier, J. Bellmunt, and S. Négrier, Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival, Journal of Clinical Oncology, vol.28, issue.13, pp.2144-2150, 2010.
DOI : 10.1200/JCO.2009.26.7849

R. Motzer, B. Escudier, and S. Oudard, Phase 3 trial of everolimus for metastatic renal cell carcinoma, Cancer, vol.356, issue.suppl, pp.4256-4265, 2010.
DOI : 10.1002/cncr.25219

B. Escudier, T. Eisen, and W. Stadler, Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma, New England Journal of Medicine, vol.356, issue.2, pp.125-134, 2007.
DOI : 10.1056/NEJMoa060655

R. Weichselbaum and S. Hellman, Oligometastases revisited, Nature Reviews Clinical Oncology, vol.113, pp.378-382, 2011.
DOI : 10.1038/nrclinonc.2011.44

S. Naito, N. Yamamoto, and T. Takayama, Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients, European Urology, vol.57, issue.2, pp.317-326, 2010.
DOI : 10.1016/j.eururo.2008.12.026

Y. Niibe and . Hay, Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy, Japanese Journal of Clinical Oncology, vol.40, issue.2, pp.107-111, 2010.
DOI : 10.1093/jjco/hyp167

Y. Niibe and J. Chang, Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature, Pulmonary Medicine, vol.2012, issue.2, pp.1-5, 2012.
DOI : 10.1200/JCO.2008.19.6329

F. Cornelis, O. Saut, and P. Cumsille, In vivo mathematical modeling of tumor growth from imaging data: Soon to come in the future?, Diagnostic and Interventional Imaging, vol.94, issue.6, pp.593-600, 2013.
DOI : 10.1016/j.diii.2013.03.001

URL : https://hal.archives-ouvertes.fr/hal-01038054

Y. Lussier, N. Khodarev, and K. Regan, Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs, PLoS ONE, vol.25, issue.12, p.50141, 2012.
DOI : 10.1371/journal.pone.0050141.s007

Y. Lussier, H. Xing, and J. Salama, MicroRNA Expression Characterizes Oligometastasis(es), PLoS ONE, vol.7, issue.12, p.28650, 2011.
DOI : 10.1371/journal.pone.0028650.s011

URL : http://doi.org/10.1371/journal.pone.0028650

S. Park, A. Gaur, E. Lengyel, and M. Peter, The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2, Genes & Development, vol.22, issue.7, pp.894-907, 2008.
DOI : 10.1101/gad.1640608

C. Nakada, K. Matsuura, and Y. Tsukamoto, Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c, The Journal of Pathology, vol.212, issue.4, pp.418-427, 2008.
DOI : 10.1002/path.2437

H. Peinado, D. Olmeda, and A. Cano, Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?, Nature Reviews Cancer, vol.176, issue.6, pp.415-428, 2007.
DOI : 10.1038/nrc2131

N. Bushati and S. Cohen, microRNA Functions, Annual Review of Cell and Developmental Biology, vol.23, issue.1, pp.175-205, 2007.
DOI : 10.1146/annurev.cellbio.23.090506.123406

M. Du, D. Lu, and Q. Wang, Genetic variations in microRNAs and the risk and survival of renal cell cancer, Carcinogenesis, vol.35, issue.7, 2014.
DOI : 10.1093/carcin/bgu082

Y. Huang, Y. Dai, and J. Yang, Microarray analysis of microRNA expression in renal clear cell carcinoma, European Journal of Surgical Oncology (EJSO), vol.35, issue.10, pp.1119-1123, 2009.
DOI : 10.1016/j.ejso.2009.04.010

D. Juan, G. Alexe, and T. Antes, Identification of a MicroRNA Panel for Clear-cell Kidney Cancer, Urology, vol.75, issue.4, pp.835-841, 2010.
DOI : 10.1016/j.urology.2009.10.033

C. Nakada, K. Matsuura, and Y. Tsukamoto, Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c, The Journal of Pathology, vol.212, issue.4, pp.418-427, 2008.
DOI : 10.1002/path.2437

C. Roth, B. Rack, and V. Müller, Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer, Breast Cancer Research, vol.219, issue.6, p.90, 2010.
DOI : 10.1002/path.2586

H. Hofmann, H. Neef, and K. Krohe, Prognostic Factors and Survival after Pulmonary Resection of Metastatic Renal Cell Carcinoma, European Urology, vol.48, issue.1, pp.77-82, 2005.
DOI : 10.1016/j.eururo.2005.03.004

P. Rao, B. Escudier, and T. De-baere, Spontaneous Regression of Multiple Pulmonary Metastases After Radiofrequency Ablation of a Single Metastasis, CardioVascular and Interventional Radiology, vol.11, issue.2, pp.424-430, 2011.
DOI : 10.1007/s00270-010-9896-9

M. Ellis, C. Hessman, and R. Weerasinghe, Comparison of pulmonary nodule detection rates between preoperative CT imaging and intraoperative lung palpation, The American Journal of Surgery, vol.201, issue.5, pp.619-622, 2011.
DOI : 10.1016/j.amjsurg.2011.01.005

E. Park, J. Goo, and J. Lee, Efficacy of Computer-Aided Detection System and Thin-Slab Maximum Intensity Projection Technique in the Detection of Pulmonary Nodules in Patients With Resected Metastases, Investigative Radiology, vol.44, issue.2, pp.105-113, 2009.
DOI : 10.1097/RLI.0b013e318190fcfc

S. Renaud, P. Falcoz, and M. Alifano, Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: An 18 years of experience, Journal of Surgical Oncology, vol.33, issue.8, pp.823-829, 2014.
DOI : 10.1002/jso.23593

S. Renaud, P. Falcoz, A. Olland, and G. Massard, Should mediastinal lymphadenectomy be performed during lung metastasectomy of renal cell carcinoma?, Interactive CardioVascular and Thoracic Surgery, vol.16, issue.4, pp.525-528, 2013.
DOI : 10.1093/icvts/ivs534

S. Saisho, M. Nakata, and S. Sawada, Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: 11-years of experience, Surgical Endoscopy, vol.127, issue.1, pp.55-61, 2009.
DOI : 10.1007/s00464-008-9895-y

S. Shiono, G. Ishii, and K. Nagai, Predictive Factors for Local Recurrence of Resected Colorectal Lung Metastases, The Annals of Thoracic Surgery, vol.80, issue.3, pp.1040-1045, 2005.
DOI : 10.1016/j.athoracsur.2004.12.033

J. Kavolius, D. Mastorakos, and C. Pavlovich, Resection of metastatic renal cell carcinoma., Journal of Clinical Oncology, vol.16, issue.6, pp.2261-2266, 1998.
DOI : 10.1200/JCO.1998.16.6.2261

G. Meimarakis, A. M. Staehler, and M. , Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases, The American Journal of Surgery, vol.202, issue.2, pp.158-167, 2011.
DOI : 10.1016/j.amjsurg.2010.06.029

F. Stéphan, S. Boucheseiche, and J. Hollande, Pulmonary Complications Following Lung Resection, Chest, vol.118, issue.5, pp.1263-1270, 2000.
DOI : 10.1378/chest.118.5.1263

N. Soga, K. Yamakado, and H. Gohara, Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma, BJU International, vol.13, issue.6, pp.790-794, 2009.
DOI : 10.1111/j.1464-410X.2009.08459.x

S. Y. Huo, A. , L. Morris, D. King, J. Glenn et al., Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma, Ann Surg Oncol, vol.16, pp.3169-3175, 2009.

F. Detterbeck, Radiofrequency Ablation (RFA) of Pulmonary Metastases: Technical Success vs. Actual Benefit, Annals of Surgical Oncology, vol.4, issue.4, 1214.
DOI : 10.1245/s10434-009-0905-7

T. Hiraki, H. Mimura, and H. Gobara, Repeat Radiofrequency Ablation for Local Progression of Lung Tumors: Does It Have a Role in Local Tumor Control?, Journal of Vascular and Interventional Radiology, vol.19, issue.5, pp.706-711, 2008.
DOI : 10.1016/j.jvir.2007.12.441

H. Bang, P. Littrup, and D. Goodrich, Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor cont rol: feasibility, outcomes, and estimated cost -effectiveness for palliation, 2012.

Y. Sano, S. Kanazawa, and H. Mimura, A Novel Strategy for Treatment of Metastatic Pulmonary Tumors: Radiofrequency Ablation in Conjunction with Surgery, Journal of Thoracic Oncology, vol.3, issue.3, pp.283-288, 2008.
DOI : 10.1097/JTO.0b013e3181645443

J. Widder, T. Klinkenberg, and J. Ubbels, Pulmonary oligometastases: Metastasectomy or stereotactic ablative radiotherapy?, Radiotherapy and Oncology, vol.107, issue.3, pp.409-413, 2013.
DOI : 10.1016/j.radonc.2013.05.024

U. Ricardi, A. R. Filippi, and A. Guarneri, Stereotactic body radiation therapy for lung metastases, Lung Cancer, vol.75, issue.1, pp.77-81, 2012.
DOI : 10.1016/j.lungcan.2011.04.021

E. Fokas, M. Henzel, and K. Hamm, Radiotherapy for Brain Metastases from Renal Cell Cancer: Should Whole-Brain Radiot herapy Be Added to Stereotactic Radiosurgery ? Strahlent her, Onkol, vol.186, pp.210-217, 2010.

G. Hunter, E. Balagamwala, and S. Koyfman, The efficacy of external beam radiotherapy and stereotactic body radiotherapy for painful spinal metastases from renal cell carcinoma, Practical Radiation Oncology, vol.2, issue.4, pp.95-100, 2012.
DOI : 10.1016/j.prro.2012.01.005

M. Zelefsky, C. Greco, and R. Motzer, Tumor Control Outcomes After Hypofractionated and Single-Dose Stereotactic Image-Guided Intensity-Modulated Radiotherapy for Extracranial Metastases From Renal Cell Carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.5, pp.1744-1748, 2012.
DOI : 10.1016/j.ijrobp.2011.02.040

T. Baère and . De, Lung Tumor Radiofrequency Ablation: Where Do We Stand?, CardioVascular and Interventional Radiology, vol.20, issue.3, pp.241-251, 2011.
DOI : 10.1007/s00270-010-9860-8

K. Steinke, K. Haghighi, S. Wulf, and D. Morris, Effect of vessel diameter on the creation of ovine lung radiofrequency lesions in vivo: Preliminary results, Journal of Surgical Research, vol.124, issue.1, pp.85-91, 2005.
DOI : 10.1016/j.jss.2004.09.008

J. Palussière, B. Marcet, and E. Descat, Lung Tumors Treated With Percutaneous Radiofrequency Ablation: Computed Tomography Imaging Follow-Up, CardioVascular and Interventional Radiology, vol.18, issue.Suppl 4, pp.989-997, 2011.
DOI : 10.1007/s00270-010-0048-z

F. Rasmussen and H. Madsen, Imaging follow-up of RF ablation of lung tumours. Cancer Imaging Off Publ Int Canc er Imaging Soc 11 Spec No A, pp.123-128, 2011.

F. Abtin, J. Eradat, and A. Gutierrez, Radiofrequency Ablation of Lung Tumors: Imaging Features of the Postablation Zone, RadioGraphics, vol.32, issue.4, pp.947-969, 2012.
DOI : 10.1148/rg.324105181

K. Chu and D. Dupuy, Thermal ablation of tumours: biological mechanisms and advances in therapy, Nature Reviews Cancer, vol.37, issue.3, pp.199-208, 2014.
DOI : 10.1038/nrc3672

E. Anderson, W. Lees, and A. Gillams, Early Indicators of Treatment Success After Percutaneous Radiofrequency of Pulmonary Tumors, CardioVascular and Interventional Radiology, vol.20, issue.3, pp.478-483, 2009.
DOI : 10.1007/s00270-008-9482-6

Y. Miao, Y. Ni, and H. Bosmans, Radiofrequency Ablation for Eradication of Pulmonary Tumor in Rabbits, Journal of Surgical Research, vol.99, issue.2, pp.265-271, 2001.
DOI : 10.1006/jsre.2001.6208

C. Gadaleta, V. Mattioli, and G. Colucci, Radiofrequency Ablation of 40 Lung Neoplasms: Preliminary Results, American Journal of Roentgenology, vol.183, issue.2, pp.361-368, 2004.
DOI : 10.2214/ajr.183.2.1830361

A. Yamamoto, K. Nakamura, and T. Matsuoka, Radiofrequency Ablation in a Porcine Lung Model: Correlation Between CT and Histopathologic Findings, American Journal of Roentgenology, vol.185, issue.5, pp.1299-1306, 2005.
DOI : 10.2214/AJR.04.0968

A. Singnurkar, S. Solomon, and M. Gönen, 18F-FDG PET/CT for the Prediction and Detection of Local Recurrence After Radiofrequency Ablation of Malignant Lung Lesions, Journal of Nuclear Medicine, vol.51, issue.12, pp.1833-1840, 2010.
DOI : 10.2967/jnumed.110.076778

S. Harada, S. Sato, and E. Suzuki, The usefulness of pre-radiofrequency ablation SUV(max) in 18F-FDG PET/CT to predict the risk of a local recurrence of malignant lung tumors after lung radiofrequency ablation, Acta Med Okayama, vol.65, pp.395-402, 2011.

F. Bonichon, J. Palussière, and Y. Godbert, Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study, European Journal of Nuclear Medicine and Molecular Imaging, vol.18, issue.3, pp.1817-1827, 2013.
DOI : 10.1007/s00259-013-2521-9

T. Baère, J. De, and A. Aupérin, Midterm Local Efficacy and Survival after Radiofrequency Ablation of Lung Tumors with Minimum Follow-up of 1 Year: Prospective Evaluation, Radiology, vol.240, issue.2, pp.587-596, 2006.
DOI : 10.1148/radiol.2402050807

X. Hu, F. Zhang, and X. Liu, Efficacy and Potential MicroRNA Mechanism for Computed Tomography-Guided Percutaneous Radiofrequency Ablation of Primary Lung Cancer and Lung Metastasis from Liver Cancer, Cellular Physiology and Biochemistry, vol.33, issue.5, pp.1261-1271, 2014.
DOI : 10.1159/000358694

M. Kashima, K. Yamakado, and H. Takaki, Complications After 1000 Lung Radiofrequency Ablation Sessions in 420 Patients: A Single Center???s Experiences, American Journal of Roentgenology, vol.197, issue.4, pp.576-580, 2011.
DOI : 10.2214/AJR.11.6408

A. Gillams and W. Lees, Analysis of the factors associated with radiofrequency ablation-induced pneumothorax, Clinical Radiology, vol.62, issue.7, pp.639-644, 2007.
DOI : 10.1016/j.crad.2007.02.005

J. Palussière, M. Canella, and F. Cornelis, Retrospective review of thoracic neural damage during lung ablation ??? what the interventional radiologist needs to know about neural thoracic anatomy, CardioVascular and Interventional Radiology, vol.260, issue.2, pp.1602-1613, 2013.
DOI : 10.1007/s00270-013-0597-z

E. Alexander, C. Hankins, and J. Machan, Rib Fractures after Percutaneous Radiofrequency and Microwave Ablation of Lung Tumors: Incidence and Relevance, Radiology, vol.266, issue.3, pp.971-978, 2013.
DOI : 10.1148/radiol.12120933

A. Jeannin, P. Saignac, and J. Palussière, Massive Systemic Air Embolism During Percutaneous Radiofrequency Ablation of a Primary Lung Tumor, Anesthesia & Analgesia, vol.109, issue.2, pp.484-486, 2009.
DOI : 10.1213/ane.0b013e3181aad6d7

L. Burgoyne, L. Pereiras, and F. Laningham, Near-fatal acute bronchovenous fistula in a child undergoing radiofrequency ablation of a metastatic lung tumor, Pediatric Anesthesia, vol.73, issue.11, pp.1131-1133, 2008.
DOI : 10.1111/j.1460-9592.2008.02642.x

M. Cannella, F. Cornelis, and E. Descat, Bronchopleural Fistula After Radiofrequency Ablation of Lung Tumours, CardioVascular and Interventional Radiology, vol.119, issue.S2, pp.171-174, 2011.
DOI : 10.1007/s00270-010-9826-x

A. Cahalane, R. Kelly, O. Neill, and A. , Bronchopleural Cutaneous Fistula after Pulmonary Radiofrequency Ablation: Treatment with Low-Adherent Paraffin Gauze Dressing, Journal of Vascular and Interventional Radiology, vol.23, issue.2, pp.283-285, 2012.
DOI : 10.1016/j.jvir.2011.10.016

N. Alberti, G. Ferretti, and X. Buy, Diaphragmatic Hernia After Lung P ercutaneous Radiofrequency Ablation: Incidence and Risk Factors, Cardiovasc Int ervent Radiol, pp.1-7, 2014.

N. Alberti, N. Frulio, and H. Trillaud, Pulmonary Aspergilloma in a Cavity Formed After Percutaneous Radiofrequency Ablation, CardioVascular and Interventional Radiology, vol.20, issue.2, pp.537-540, 2014.
DOI : 10.1007/s00270-013-0631-1

J. Soh, S. Toyooka, and H. Gobara, A Case of Delayed Massive Hemothorax Caused by the Rupture of a Pulmonary Artery Pseudoaneurysm after Radiofrequency Ablation of Lung Tumors, Japanese Journal of Clinical Oncology, vol.42, issue.7, pp.646-649, 2012.
DOI : 10.1093/jjco/hys068

A. Gillams and W. Lees, Radiofrequency ablation of lung metastases: factors influencing success, European Radiology, vol.16, issue.11, pp.672-677, 2008.
DOI : 10.1007/s00330-007-0811-y

T. Lesser, F. Ritter, and H. Schlosser, Effects of Radiofrequency Ablation on Normal Lung Tissue in a Swine Model, Academic Radiology, vol.18, issue.10, pp.1318-1323, 2011.
DOI : 10.1016/j.acra.2011.06.010

T. Hiraki, H. Mimura, and H. Gobara, Repeat Radiofrequency Ablation for Local Progression of Lung Tumors: Does It Have a Role in Local Tumor Control?, Journal of Vascular and Interventional Radiology, vol.19, issue.5, pp.706-711, 2008.
DOI : 10.1016/j.jvir.2007.12.441

J. Shuster, Median follow-up in clinical trials., Journal of Clinical Oncology, vol.9, issue.1, pp.191-192, 1991.
DOI : 10.1200/JCO.1991.9.1.191

S. Goldberg, C. Grassi, and J. Cardella, Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria, Journal of Vascular and Interventional Radiology, vol.20, issue.7, pp.377-390, 2009.
DOI : 10.1016/j.jvir.2009.04.011

J. Palussière, F. Gómez, and M. Cannella, Single-Session Radiofrequency Ablation of Bilateral Lung Metastases, CardioVascular and Interventional Radiology, vol.17, issue.Suppl 2, pp.852-859, 2012.
DOI : 10.1007/s00270-011-0191-1

N. Hoffmann, M. Gillett, and J. Cheville, Differences in Organ System of Distant Metastasis by Renal Cell Carcinoma Subtype, The Journal of Urology, vol.179, issue.2, pp.474-477, 2008.
DOI : 10.1016/j.juro.2007.09.036

Y. Kyoda, K. Kobayashi, and M. Hirobe, Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10??years after initial treatment, International Journal of Clinical Oncology, vol.39, issue.1, pp.146-151, 2014.
DOI : 10.1007/s10147-013-0533-x

R. Siegel, J. Ma, Z. Zou, and A. Jemal, Cancer statistics, 2014, Cancer statistics, pp.9-29, 2014.
DOI : 10.3322/caac.21208

A. Zisman, A. Pantuck, and J. Wieder, Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma, Journal of Clinical Oncology, vol.20, issue.23, pp.4559-4566, 2002.
DOI : 10.1200/JCO.2002.05.111

P. Russo, T. Jang, and J. Pettus, Survival rates after resection for localized kidney cancer: 1989 to 2004, Cancer, vol.7, issue.1, pp.84-96, 1989.
DOI : 10.1002/cncr.23520

A. Antonelli, A. Cozzoli, and D. Zani, The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol, BJU International, vol.17, issue.2, pp.296-300, 2007.
DOI : 10.1111/j.1464-410X.2005.05771.x

S. Eggener, O. Yossepowitch, and J. Pettus, Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence, Journal of Clinical Oncology, vol.24, issue.19, pp.3101-3106, 2006.
DOI : 10.1200/JCO.2005.04.8280

M. Meskawi, M. Sun, and Q. Trinh, A Review of Integrated Staging Systems for Renal Cell Carcinoma, European Urology, vol.62, issue.2, pp.303-314, 2012.
DOI : 10.1016/j.eururo.2012.04.049

R. Hoffmann, T. Jakobs, and A. Lubienski, Percutaneous radiofrequency ablation of pulmonary tumors???Is there a difference between treatment under general anaesthesia and under conscious sedation?, European Journal of Radiology, vol.59, issue.2, pp.168-174, 2006.
DOI : 10.1016/j.ejrad.2006.04.010

K. Yasui, S. Kanazawa, and Y. Sano, Thoracic Tumors Treated with CT-guided Radiofrequency Ablation: Initial Experience, Radiology, vol.231, issue.3, pp.850-857, 2004.
DOI : 10.1148/radiol.2313030347

J. Lee, G. Jin, and S. Goldberg, Percutaneous Radiofrequency Ablation for Inoperable Non???Small Cell Lung Cancer and Metastases: Preliminary Report, Radiology, vol.230, issue.1, pp.125-134, 2004.
DOI : 10.1148/radiol.2301020934

J. B. Battistuzzi and J. Palussiere, Le scanner est-il la référence pour le guidage lors de radiofréquences pulmonaires ?, 2013.

O. Yaycioglu, W. Roberts, and T. Chan, Prognostic assessment of nonmetastatic renal cell carcinoma: a clinically based model, Urology, vol.58, issue.2, pp.141-145, 2001.
DOI : 10.1016/S0090-4295(01)01207-9

S. Eggener, O. Yossepowitch, and S. Kundu, Risk Score and Metastasectomy Independently Impact Prognosis of Patients With Recurrent Renal Cell Carcinoma, The Journal of Urology, vol.180, issue.3, pp.873-878, 2008.
DOI : 10.1016/j.juro.2008.05.006

J. Yang, J. Abad, and R. Sherry, Treatment of Oligometastases After Successful Immunotherapy, Seminars in Radiation Oncology, vol.16, issue.2, pp.131-135, 2006.
DOI : 10.1016/j.semradonc.2005.12.008

J. Kim, J. Park, and Y. Wang, Surgical Resection of Pulmonary Metastasis from Renal Cell Carcinoma, The Korean Journal of Thoracic and Cardiovascular Surgery, vol.44, issue.2, p.159, 2011.
DOI : 10.5090/kjtcs.2011.44.2.159

F. Chen, T. Fujinaga, and T. Shoji, Pulmonary resection for metastasis from renal cell carcinoma, Interactive CardioVascular and Thoracic Surgery, vol.7, issue.5, pp.825-828, 2008.
DOI : 10.1510/icvts.2008.181065

U. Pastorino, P. Mccormack, and R. Ginsberg, A new staging propos al for pulmonary metastases. The results of analysis of 5206 cases of resected pulmonary metastases, Chest Surg Clin N Am, vol.8, pp.197-202, 1998.

M. Casiraghi, D. Pas, T. Maisonneuve, and P. , A 10-Year Single-Center Experience on 708 Lung Metastasectomies: The Evidence of the ???International Registry of Lung Metastases???, Journal of Thoracic Oncology, vol.6, issue.8, pp.1373-1378, 2011.
DOI : 10.1097/JTO.0b013e3182208e58

H. Hofmann, H. Neef, and K. Krohe, Prognostic Factors and Survival after Pulmonary Resection of Metastatic Renal Cell Carcinoma, European Urology, vol.48, issue.1, pp.77-81, 2005.
DOI : 10.1016/j.eururo.2005.03.004

S. Renaud, P. E. Falcoz, and M. Alifano, Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: An 18 years of experience, Journal of Surgical Oncology, vol.33, issue.8, pp.823-829, 2014.
DOI : 10.1002/jso.23593

T. Choueiri, B. Rini, and J. Garcia, Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma, Annals of Oncology, vol.18, issue.2, pp.249-255, 2007.
DOI : 10.1093/annonc/mdl371

T. Mekhail, R. Abou-jawde, and G. Boumerhi, Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma, Journal of Clinical Oncology, vol.23, issue.4, pp.832-841, 2005.
DOI : 10.1200/JCO.2005.05.179

K. Yamakado, S. Hase, and T. Matsuoka, Radiofrequency Ablation for the Treatment of Unresectable Lung Metastases in Patients with Colorectal Cancer: A Multicenter Study in Japan, Journal of Vascular and Interventional Radiology, vol.18, issue.3, pp.393-398, 2007.
DOI : 10.1016/j.jvir.2006.11.003

G. Raj, R. Thompson, and B. Leibovich, Preoperative Nomogram Predicting 12-Year Probability of Metastatic Renal Cancer, The Journal of Urology, vol.179, issue.6, pp.2146-2151, 2008.
DOI : 10.1016/j.juro.2008.01.101

R. Iacovelli, E. Lanoy, L. Albiges, and B. Escudier, Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma, BJU International, vol.59, issue.11, pp.1747-1753, 2012.
DOI : 10.1111/j.1464-410X.2012.11518.x

S. Cho, I. Song, H. Yang, and S. Jheon, Prognostic factors of pulmonary metastasis from colorectal carcinoma, Interactive CardioVascular and Thoracic Surgery, vol.17, issue.2, pp.303-307, 2013.
DOI : 10.1093/icvts/ivt164

W. Kendal, Oligometastasis as a predictor for occult disease, Mathematical Biosciences, vol.251, pp.1-10, 2014.
DOI : 10.1016/j.mbs.2014.02.006

A. Gillams, Z. Khan, P. Osborn, and W. Lees, Survival after Radiofrequency Ablation in 122 Patients with Inoperable Colorectal Lung Metastases, CardioVascular and Interventional Radiology, vol.76, issue.3, pp.724-730, 2013.
DOI : 10.1007/s00270-012-0500-3

T. Hiraki, H. Gobara, and H. Mimura, Percutaneous radiofrequency ablation of clinical stage I non???small cell lung cancer, The Journal of Thoracic and Cardiovascular Surgery, vol.142, issue.1, pp.24-30, 2011.
DOI : 10.1016/j.jtcvs.2011.02.036

J. Palussière, M. Canella, and F. Cornelis, Retrospective review of thoracic neural damage during lung ablation ??? what the interventional radiologist needs to know about neural thoracic anatomy, CardioVascular and Interventional Radiology, vol.260, issue.2, pp.1602-1613, 2013.
DOI : 10.1007/s00270-013-0597-z

N. Nour-eldin, N. Naguib, and M. Mack, Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening pattern, European Radiology, vol.193, issue.1, pp.197-204, 2011.
DOI : 10.1007/s00330-010-1889-1

Y. Sano, S. Kanazawa, and H. Gobara, Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies, Cancer, vol.183, issue.7, pp.1397-1405, 2007.
DOI : 10.1002/cncr.22541